1,1-dichloroethene increases expression ISO RGD:1317681 6480464 vinylidene chloride results in increased expression of PLAC8 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:1317681 6480464 1, 2-Dimethylhydrazine results in decreased expression of PLAC8 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1317681 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLAC8 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression ISO RGD:1308102 6480464 1-Naphthylisothiocyanate results in increased expression of PLAC8 mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression ISO RGD:1308102 6480464 Ethinyl Estradiol results in increased expression of PLAC8 mRNA CTD PMID:17557909 17beta-estradiol increases expression ISO RGD:1317681 6480464 Estradiol results in increased expression of PLAC8 mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO RGD:1308102 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of PLAC8 mRNA, [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLAC8 mRNA CTD PMID:26496021 , PMID:32741896 17beta-estradiol 3-benzoate multiple interactions ISO RGD:1308102 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLAC8 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PLAC8 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1308102 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLAC8 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PLAC8 mRNA CTD PMID:21632981 , PMID:26238291 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1308102 6480464 Tetrachlorodibenzodioxin results in increased expression of PLAC8 mRNA CTD PMID:21215274 3-chloropropane-1,2-diol decreases expression ISO RGD:1308102 6480464 alpha-Chlorohydrin results in decreased expression of PLAC8 mRNA CTD PMID:28522335 4,4'-diaminodiphenylmethane increases expression ISO RGD:1308102 6480464 4, 4'-diaminodiphenylmethane results in increased expression of PLAC8 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:1317681 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PLAC8 mRNA CTD PMID:30951980 4-amino-2,6-dinitrotoluene affects expression ISO RGD:1308102 6480464 4-amino-2, 6-dinitrotoluene affects the expression of PLAC8 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression ISO RGD:1317681 6480464 Fenretinide results in increased expression of PLAC8 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression ISO RGD:1308102 6480464 Propylthiouracil results in decreased expression of PLAC8 mRNA CTD PMID:24780913 acetamide increases expression ISO RGD:1308102 6480464 acetamide results in increased expression of PLAC8 mRNA CTD PMID:31881176 acetamiprid increases expression ISO RGD:1308102 6480464 acetamiprid results in increased expression of PLAC8 mRNA CTD PMID:27782041 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of PLAC8 protein CTD PMID:20106945 aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of PLAC8 gene CTD PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PLAC8 mRNA CTD PMID:21641981 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of PLAC8 mRNA CTD PMID:33167477 antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of PLAC8 mRNA CTD PMID:24449571 atrazine affects methylation ISO RGD:1308102 6480464 Atrazine affects the methylation of PLAC8 gene CTD PMID:28931070 benzo[a]pyrene decreases expression ISO RGD:1317681 6480464 Benzo(a)pyrene results in decreased expression of PLAC8 mRNA CTD PMID:21569818 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of PLAC8 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of PLAC8 mRNA CTD PMID:21632981 , PMID:26238291 benzo[a]pyrene increases expression ISO RGD:1317681 6480464 Benzo(a)pyrene results in increased expression of PLAC8 mRNA CTD PMID:22228805 benzo[a]pyrene multiple interactions ISO RGD:1317681 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLAC8 mRNA, AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PLAC8 mRNA] CTD PMID:22228805 , PMID:27858113 benzo[b]fluoranthene multiple interactions ISO RGD:1317681 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLAC8 mRNA CTD PMID:27858113 bisphenol A multiple interactions ISO RGD:1308102 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of PLAC8 mRNA CTD PMID:26496021 bisphenol A decreases expression ISO RGD:1317681 6480464 bisphenol A results in decreased expression of PLAC8 mRNA CTD PMID:35479511 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PLAC8 mRNA CTD PMID:32028606 bisphenol A increases expression ISO RGD:1317681 6480464 bisphenol A results in increased expression of PLAC8 mRNA CTD PMID:34585602 bisphenol A decreases expression ISO RGD:1308102 6480464 bisphenol A results in decreased expression of PLAC8 mRNA CTD PMID:25181051 , PMID:34947998 cadmium dichloride decreases methylation ISO RGD:1308102 6480464 Cadmium Chloride results in decreased methylation of PLAC8 promoter CTD PMID:22457795 cadmium dichloride increases expression ISO RGD:1308102 6480464 Cadmium Chloride results in increased expression of PLAC8 mRNA CTD PMID:25993096 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of PLAC8 mRNA CTD PMID:25511174 carbon nanotube increases expression ISO RGD:1317681 6480464 Nanotubes more ... CTD PMID:25554681 chloroprene decreases expression ISO RGD:1317681 6480464 Chloroprene results in decreased expression of PLAC8 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:1317681 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLAC8 mRNA CTD PMID:20938992 chrysene multiple interactions ISO RGD:1317681 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLAC8 mRNA CTD PMID:27858113 ciglitazone multiple interactions EXP 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of PLAC8 mRNA CTD PMID:16197558 cisplatin increases expression ISO RGD:1317681 6480464 Cisplatin results in increased expression of PLAC8 mRNA CTD PMID:21151649 clofibrate multiple interactions ISO RGD:1317681 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PLAC8 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PLAC8 mRNA] CTD PMID:17585979 clofibrate decreases expression ISO RGD:1317681 6480464 Clofibrate results in decreased expression of PLAC8 mRNA CTD PMID:17585979 copper atom decreases expression ISO RGD:1308102 6480464 Copper results in decreased expression of PLAC8 mRNA CTD PMID:30556269 copper(0) decreases expression ISO RGD:1308102 6480464 Copper results in decreased expression of PLAC8 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of PLAC8 mRNA CTD PMID:19549813 Cuprizon increases expression ISO RGD:1308102 6480464 Cuprizone results in increased expression of PLAC8 mRNA CTD PMID:27523638 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of PLAC8 mRNA CTD PMID:20106945 dibutyl phthalate increases expression ISO RGD:1308102 6480464 Dibutyl Phthalate results in increased expression of PLAC8 mRNA CTD PMID:21266533 dichlorine increases expression ISO RGD:1317681 6480464 Chlorine results in increased expression of PLAC8 mRNA CTD PMID:30189237 diclofenac increases expression ISO RGD:1317681 6480464 Diclofenac results in increased expression of PLAC8 mRNA CTD PMID:26934552 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of PLAC8 mRNA CTD PMID:26516004 diuron decreases expression ISO RGD:1308102 6480464 Diuron results in decreased expression of PLAC8 mRNA CTD PMID:25152437 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLAC8 mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:1317681 6480464 Doxorubicin results in increased expression of PLAC8 mRNA CTD PMID:15033991 ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of PLAC8 mRNA CTD PMID:23649840 folic acid multiple interactions ISO RGD:1317681 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folic acid increases expression ISO RGD:1317681 6480464 Folic Acid results in increased expression of PLAC8 mRNA CTD PMID:25629700 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of PLAC8 mRNA CTD PMID:23649840 furan increases expression ISO RGD:1308102 6480464 furan results in increased expression of PLAC8 mRNA CTD PMID:27387713 gentamycin increases expression ISO RGD:1308102 6480464 Gentamicins results in increased expression of PLAC8 mRNA CTD PMID:22061828 glafenine increases expression ISO RGD:1308102 6480464 Glafenine results in increased expression of PLAC8 mRNA CTD PMID:24136188 L-methionine multiple interactions ISO RGD:1317681 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLAC8 mRNA CTD PMID:20938992 lead diacetate decreases expression ISO RGD:1317681 6480464 lead acetate results in decreased expression of PLAC8 mRNA CTD PMID:21829687 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of PLAC8 mRNA CTD PMID:28988120 lidocaine decreases expression ISO RGD:1308102 6480464 Lidocaine results in decreased expression of PLAC8 mRNA CTD PMID:35283115 lipopolysaccharide increases expression ISO RGD:1317681 6480464 Lipopolysaccharides results in increased expression of PLAC8 mRNA CTD PMID:27339419 lipopolysaccharide multiple interactions EXP 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PLAC8 mRNA CTD PMID:35811015 manganese(II) chloride increases expression ISO RGD:1308102 6480464 manganese chloride results in increased expression of PLAC8 mRNA CTD PMID:28801915 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of PLAC8 mRNA CTD PMID:24449571 methylmercury chloride increases expression ISO RGD:1308102 6480464 methylmercuric chloride results in increased expression of PLAC8 mRNA CTD PMID:31378766 Monobutylphthalate decreases expression ISO RGD:1308102 6480464 monobutyl phthalate results in decreased expression of PLAC8 mRNA CTD PMID:29162477 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1317681 6480464 MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PLAC8 mRNA] CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:1317681 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PLAC8 mRNA CTD PMID:25566086 N-nitrosodimethylamine increases expression ISO RGD:1308102 6480464 Dimethylnitrosamine results in increased expression of PLAC8 mRNA CTD PMID:25380136 nickel atom increases expression EXP 6480464 Nickel results in increased expression of PLAC8 mRNA CTD PMID:25583101 nitrofen increases expression ISO RGD:1308102 6480464 nitrofen results in increased expression of PLAC8 mRNA CTD PMID:33484710 olanzapine affects phosphorylation EXP 6480464 olanzapine affects the phosphorylation of C15 protein CTD PMID:25821032 ozone multiple interactions ISO RGD:1317681 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PLAC8 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PLAC8 mRNA CTD PMID:34911549 paracetamol multiple interactions ISO RGD:1317681 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PLAC8 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PLAC8 mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PLAC8 mRNA CTD PMID:26690555 paracetamol affects expression ISO RGD:1317681 6480464 Acetaminophen affects the expression of PLAC8 mRNA CTD PMID:17562736 pentachlorophenol decreases expression ISO RGD:1317681 6480464 Pentachlorophenol results in decreased expression of PLAC8 mRNA CTD PMID:23892564 perfluorononanoic acid decreases expression EXP 6480464 perfluoro-n-nonanoic acid results in decreased expression of PLAC8 mRNA CTD PMID:32588087 phenethyl isothiocyanate decreases expression EXP 6480464 phenethyl isothiocyanate results in decreased expression of PLAC8 mRNA CTD PMID:26678675 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLAC8 mRNA CTD PMID:27188386 potassium chromate increases expression EXP 6480464 potassium chromate(VI) results in increased expression of PLAC8 mRNA CTD PMID:22714537 progesterone increases expression ISO RGD:1317681 6480464 Progesterone results in increased expression of PLAC8 mRNA CTD PMID:22238285 propanal increases expression EXP 6480464 propionaldehyde results in increased expression of PLAC8 mRNA CTD PMID:26079696 quinolin-8-ol decreases expression EXP 6480464 Oxyquinoline results in decreased expression of PLAC8 mRNA CTD PMID:21632981 rimonabant multiple interactions ISO RGD:1317681 6480464 Rimonabant inhibits the reaction [Dietary Fats results in decreased expression of PLAC8 mRNA] CTD PMID:19030233 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PLAC8 mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine decreases expression EXP 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of PLAC8 mRNA CTD PMID:35811015 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLAC8 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1317681 6480464 Silicon Dioxide results in increased expression of PLAC8 mRNA CTD PMID:23221170 , PMID:29341224 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of PLAC8 mRNA CTD PMID:25351596 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of PLAC8 mRNA CTD PMID:34032870 sulforaphane decreases expression EXP 6480464 sulforaphane results in decreased expression of PLAC8 mRNA CTD PMID:31838189 tamoxifen affects expression ISO RGD:1317681 6480464 Tamoxifen affects the expression of PLAC8 mRNA CTD PMID:20937368 testosterone multiple interactions ISO RGD:1308102 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLAC8 mRNA CTD PMID:32741896 tetrachloromethane increases expression ISO RGD:1317681 6480464 Carbon Tetrachloride results in increased expression of PLAC8 mRNA CTD PMID:27339419 , PMID:31919559 tetraphene multiple interactions ISO RGD:1317681 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLAC8 mRNA CTD PMID:27858113 thioacetamide decreases expression ISO RGD:1308102 6480464 Thioacetamide results in decreased expression of PLAC8 mRNA CTD PMID:23411599 thioacetamide increases expression ISO RGD:1308102 6480464 Thioacetamide results in increased expression of PLAC8 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1317681 6480464 titanium dioxide results in decreased expression of PLAC8 mRNA CTD PMID:27760801 tributylstannane increases expression ISO RGD:1317681 6480464 tributyltin results in increased expression of PLAC8 mRNA CTD PMID:31939706 trimellitic anhydride increases expression ISO RGD:1317681 6480464 trimellitic anhydride results in increased expression of PLAC8 mRNA CTD PMID:19042947 tris(2-butoxyethyl) phosphate affects expression EXP 6480464 tris(2-butoxyethyl) phosphate affects the expression of PLAC8 mRNA CTD PMID:29024780 urethane decreases expression EXP 6480464 Urethane results in decreased expression of PLAC8 mRNA CTD PMID:28818685 valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of PLAC8 gene CTD PMID:29154799 vancomycin decreases expression ISO RGD:1317681 6480464 Vancomycin results in decreased expression of PLAC8 mRNA CTD PMID:18930951 vinclozolin affects expression ISO RGD:1308102 6480464 vinclozolin affects the expression of PLAC8 mRNA CTD PMID:19015723
